Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000550616 | SCV000654966 | benign | Very long chain acyl-CoA dehydrogenase deficiency | 2023-09-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000603826 | SCV000729665 | likely benign | not specified | 2018-01-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Wong Mito Lab, |
RCV000550616 | SCV001365158 | uncertain significance | Very long chain acyl-CoA dehydrogenase deficiency | 2019-11-01 | criteria provided, single submitter | clinical testing | The NM_000018.3:c.753-27C>T (NP_000009.1:p.?) [GRCH38: NC_000017.11:g.7222150C>T] variant in ACADVL gene is interpretated to be Uncertain Significance based on ACMG guidelines (PMID: 25741868). This variant has been reported. This variant dose not meet any evidence codes reported in the ACMG guidelines. |
Ce |
RCV003311848 | SCV004010551 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | ACADVL: BS1:Supporting |
Natera, |
RCV000550616 | SCV001453214 | uncertain significance | Very long chain acyl-CoA dehydrogenase deficiency | 2020-05-05 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003935524 | SCV004750177 | likely benign | ACADVL-related disorder | 2020-09-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |